Literature DB >> 14587937

Prolonged candidemia in infants following surgery for congenital heart disease.

Chandrama Chakrabarti1, Sunil K Sood, Vincent Parnell, Lorry G Rubin.   

Abstract

OBJECTIVES: To describe a group of infants with complex congenital heart disease (CCHD) who had candidemia postoperatively and to perform a case-control study of risk factors.
DESIGN: Descriptive and case-control study.
SETTING: Tertiary-care medical centers. PATIENTS: Infants with CCHD who underwent cardiac surgery and developed candidemia. Controls were matched for congenital heart disease lesions, age, and postoperative hospital stay.
RESULTS: Of 95 infants younger than 6 months with CCHD who underwent cardiac surgery between January 1999 and April 2001, 6 (6.3%) developed candidemia with 5 different species. The candidemia was prolonged (range, 12 to 32 days; median, 17 days). The interval between cardiac surgery and onset of candidemia was 12 to 57 days (median, 24 days). All had a central venous catheter inserted 8 to 50 days prior to the onset of candidemia. The mortality rate was 83%, compared with 13% for the group without candidemia. A univariate analysis of the potential risk factors revealed that duration of total parenteral nutrition (TPN), duration of antibiotics, intraoperative cardiopulmonary bypass time, and documentation of an intravascular thrombus were associated with candidemia. In multivariate analysis, long duration of TPN and documentation of a thrombus were associated with candidemia.
CONCLUSIONS: Candidemia following cardiac surgery for infants with CCHD was persistent and associated with high mortality. The variety of species indicates that this was not a common-source outbreak. Risk factors associated with candidemia were duration of TPN and documentation of an intravascular thrombus.

Entities:  

Mesh:

Year:  2003        PMID: 14587937     DOI: 10.1086/502126

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  6 in total

1.  Sepsis in young infants with congenital heart disease.

Authors:  S B Ascher; P B Smith; R H Clark; M Cohen-Wolkowiez; J S Li; K Watt; E Jacqz-Aigrain; F Kaguelidou; P Manzoni; D K Benjamin
Journal:  Early Hum Dev       Date:  2012-05       Impact factor: 2.079

2.  Sepsis in the pediatric cardiac intensive care unit.

Authors:  Derek S Wheeler; Howard E Jeffries; Jerry J Zimmerman; Hector R Wong; Joseph A Carcillo
Journal:  World J Pediatr Congenit Heart Surg       Date:  2011-07-01

Review 3.  Antifungal drug discovery through the study of invertebrate model hosts.

Authors:  R Pukkila-Worley; E Holson; F Wagner; E Mylonakis
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

4.  Fatal Postoperative Candida glabrata Septicemia in a Child with Congenital Heart Disease.

Authors:  Vasant Baradkar; Shripad Taklikar; Simit Kumar
Journal:  J Glob Infect Dis       Date:  2009-01

Review 5.  Central venous catheter (CVC) removal for patients of all ages with candidaemia.

Authors:  Susanne Janum; Arash Afshari
Journal:  Cochrane Database Syst Rev       Date:  2016-07-11

Review 6.  Candidemia in children after complex congenital heart defects surgery treated with caspofungin--our own experience and a review of literature.

Authors:  Radoslaw Jaworski; Ninela Irga; Ireneusz Haponiuk; Maciej Chojnicki; Elzbieta Arlukowicz; Mariusz Steffek; Mariusz Sroka; Katarzyna Gierat-Haponiuk; Jacek Juscinski; Lucyna Palkowska; Aneta Sendrowska; Wojciech Kosiak
Journal:  Med Sci Monit       Date:  2011-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.